However, consistent with the findings of total stage I NSCLC from the PLC dataset, TP53 mutations were significantly associated with OS, but only for patients with lung ADC and not lung SqCC (Figure 5B). The gene discussed is TP53; the disease is non-small cell lung carcinoma.